How to limit screening of patients for atheromatous renal artery stenosis in two-drug resistant hypertension?

被引:0
|
作者
Ducher, M [1 ]
Cerutti, C [1 ]
Marquand, A [1 ]
Mounier-Vehier, C [1 ]
Hanon, O [1 ]
Girerd, X [1 ]
Ader, C [1 ]
Juillard, L [1 ]
Fauvel, JP [1 ]
机构
[1] Univ Lyon 1, E Herriot Hosp, F-69365 Lyon, France
关键词
epidemiology; renal artery stenosis; renal function;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The DRASTIC model based on nine variables (age, gender, recent onset of hypertension, smoking status, body mass index (BMI), abdominal bruit, atherosclerosis, dyslipidemia and creatininemia) has been proposed to predict renal artery stenosis (RAS) occurrence. Methods: In a prospective multicenter study, the clinical usefulness of the DRASTIC model was checked in 336 patients with two-drug resistant hypertension. RAS was excluded using at least color Doppler sonography. RAS was diagnosed using at least renal angiography. The statistical dependence (Z(Rho)) analysis was applied to investigate further the relationships between each variable and presence of RAS. Results: The prevalence of RAS (n = 51) was 15%. The goodness-of-fit test that compared observed RAS to predicted RAS using the DRASTIC model was not significant. Accordingly, the multivariate logistic regression indicated that only three parameters (abdominal bruit, atherosclerotic vascular disease and BMI < 25 kg/m(2)) were significantly linked to RAS. The Z(Rho) methodology revealed that calculated renal function < 60 ml/min and age > 58 yrs (median) were alto so significantly linked to RAS. No variable or combination of variables offered satisfactory positive predictive values for the RAS diagnosis. The combination of the five significantly linked variables had a negative predictive value of 98%, and allowed RAS detection with a sensitivity of 96%. In our population, RAS screening could have been avoided in 30% of our patients screened. Conclusions: The DRASTIC model was unsuitable for clinical use in our sample population. In our population, renal arteries were considered stenosis free with a probability of 98% in refractory hypertensive overweight patients, aged <= 58 yrs, with satisfactory renal function and without both abdominal bruit and atherosclerotic vascular disease.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 50 条
  • [21] EFFECT OF RENAL ARTERY ANGIOPLASTY ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION AND ATHEROSCLEROTIC RENAL ARTERY STENOSIS
    Courand, P. Y.
    Dinic, M.
    Lorthioir, A.
    Bobrie, G.
    Sapoval, M.
    Plouin, P. F.
    Azizi, M.
    Amar, L.
    JOURNAL OF HYPERTENSION, 2017, 35 : E301 - E301
  • [22] How to manage hypertension with atherosclerotic renal artery stenosis?
    Ricco, Jean-Baptiste
    Belmonte, Romain
    Illuminati, Guilio
    Barral, Xavier
    Schneider, Fabrice
    Chavent, Bertrand
    JOURNAL OF CARDIOVASCULAR SURGERY, 2017, 58 (02): : 329 - 338
  • [23] Hypertension therapy in patients with renal artery stenosis
    Vogt, Bruno
    Maillard, Marc
    Burnier, Michel
    THERAPEUTISCHE UMSCHAU, 2012, 69 (05) : 279 - 281
  • [24] Under Pressure: Renal Artery Stenosis Treatment for Resistant Hypertension
    Hanlon, Emma L.
    Carroll, Brett J.
    Krawisz, Anna K.
    Mewaldt, Christian
    Secemsky, Eric A.
    Cluett, Jennifer L.
    HYPERTENSION, 2025, 82 (03) : 403 - 406
  • [25] Transplant renal artery stenosis in recipients with resistant arterial hypertension
    Smaliakova, Maria
    Kalachyk, Aleh
    Komissarov, Kirill
    Kozak, Oleg
    Liovina, Darya
    Plaksa, Dzmitry
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [26] Transplant renal artery stenosis in recipients with resistant arterial hypertension
    Smaliakova, Maria
    Kalachyk, Aleh
    Komissarov, Kirill
    Kozak, Oleg
    Liovina, Darya
    Plaksa, Dzmitry
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1767 - I1767
  • [27] Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis
    Szperl, Malgorzata
    Dzielinska, Zofia
    Roszczynko, Marta
    Malek, Lukasz A.
    Makowiecka-Ciesla, Magdalena
    Demkow, Marcin
    Kadziela, Jacek
    Prejbisz, Aleksander
    Florczak, Elzbieta
    Zielinski, Tomasz
    Januszewicz, Andrzej
    Ruzyllo, Witold
    MEDICAL SCIENCE MONITOR, 2008, 14 (12): : CR611 - CR616
  • [28] IS RENAL ARTERY ANGIOPLASTY AND/OR STENTING A POTENTIAL TREATMENT FOR RESISTANT HYPERTENSION IN TRANSPLANT RENAL ARTERY STENOSIS?
    Tantisattamo, Ekamol
    Chokechanachaisakul, Attasit
    Pitukweerakul, Siwadon
    Ratanasrimetha, Praveen
    Shetty, Aneesha A.
    Traitanon, Opas
    Gallon, Lorenzo
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A106 - A106
  • [30] Should Two-Drug Initial Therapy for Hypertension Be Recommended for All Patients?
    Jennifer B. Cowart
    Addison A. Taylor
    Current Hypertension Reports, 2012, 14 : 324 - 332